(Q41013689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

review article

1 reference

title

Prognosis of patients with stable angina pectoris on antianginal drug therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Sven V Eriksson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Claes Held

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author name string

N Rehnqvist

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 June 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

6D-15D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

A completed twenty-five-year follow-up study of 456 patients with angina pectoris

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

The natural history of coronary artery disease: Does medical therapy improve the prognosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Risk of coronary heart disease in subjects with chest discomfort: The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Medical therapy of chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Silent ischemia during daily life is an independent predictor of mortality in stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Therapeutic implications of ischemia in the ambulatory setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Incidence, clinical characteristics, and short-term prognosis of angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Chest pain in women: clinical, investigative, and prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Angina pectoris with normal coronary angiograms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Proischemic complications of dihydropyridine calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Platelet reactivity, exercise, and stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Atherosclerosis, calcium, and calcium antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Vascular protection from atherosclerosis: potential of calcium antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

The effects of beta-adrenergic blocking agents on atherosclerosis and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Influence of long-term metoprolol treatment on early and late exercise test performance after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

The effect of diltiazem on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Nifedipine and mortality. Grave defects in the dossier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Nifedipine in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Association between various drugs used for hypertension and risk of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Is there a role for beta-blockers in hypertensive diabetic patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

Clinical course and symptomatology of angina pectoris in a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Calcium antagonists in the treatment of ischemic heart disease: angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900301-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(96)00301-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8677897%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference